Cellectar Biosciences, Inc. Gains 36.26%
Tue, Sep 05, 2023 at 07:10 PM
Cellectar Biosciences, Inc. (CLRB:NASDAQ) jumped higher at $2.48, a gain of 36.3%. On Tue, Sep 05, 2023, CLRB:NASDAQ touched a New 2-Week High of $2.48. The stock got featured on our News Catalysts scanner on Tue, Sep 05, 2023 at 08:54 AM in the 'PRIVATE PLACEMENT' category. From Tue, Aug 22, 2023, the stock recorded 55.56% Up Days and 30.00% Green Days
About Cellectar Biosciences, Inc. (CLRB:NASDAQ)
Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.
Top 10 Gainers:
- Verb Technology Company, Inc. (VERB:NASDAQ), 347.24%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 55.17%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 52.7%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 50%
- GD Culture Group Ltd Com (New) (GDC:NASDAQ), 48.01%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 36.26%
- Akso Health Group (AHG:NASDAQ), 32.41%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 31.67%
- Digital Brands Group Inc. (DBGI:NASDAQ), 31.56%
- Applied Molecular Transport Inc. (AMTI:NASDAQ), 30.18%